Heba H. Awad

ORCID: 0000-0002-7046-288X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Computational Drug Discovery Methods
  • Drug Solubulity and Delivery Systems
  • Synthesis of β-Lactam Compounds
  • Childhood Cancer Survivors' Quality of Life
  • Mesenchymal stem cell research
  • Advanced Glycation End Products research
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Graphene and Nanomaterials Applications
  • Chemotherapy-related skin toxicity
  • Tendon Structure and Treatment
  • Alzheimer's disease research and treatments
  • Analytical Methods in Pharmaceuticals
  • Carbon Nanotubes in Composites
  • MicroRNA in disease regulation
  • Cell death mechanisms and regulation
  • Amino Acid Enzymes and Metabolism
  • Extracellular vesicles in disease
  • Advanced Drug Delivery Systems
  • Tryptophan and brain disorders
  • Acute Lymphoblastic Leukemia research
  • Ocular Surface and Contact Lens
  • Heavy Metal Exposure and Toxicity
  • Pain Mechanisms and Treatments
  • Nanoparticles: synthesis and applications
  • Osteoarthritis Treatment and Mechanisms

October University of Modern Sciences and Arts
2021-2025

Minia University
2020

Abstract Dysregulation of protein homeostasis, proteostasis, is a distinctive hallmark many neurodegenerative disorders and aging. Deleteriously, the accumulation aberrant proteins in Alzheimer’s disease (AD) accompanied with marked collapse proteostasis network. The current study explored potential therapeutic effect vardenafil (VAR), phosphodiesterase-5 inhibitor, AlCl 3 / d -galactose ( -gal)-induced AD rats its possible underlying mechanisms. impact VAR treatment on neurobehavioral...

10.1007/s10787-023-01287-w article EN cc-by Inflammopharmacology 2023-07-17

Among the independent risk factors for occurrence of cardiovascular diseases like atherosclerosis is hyperlipidemia. To decrease events and patient mortality, antihyperlipidemia therapy crucial. Our study aimed to enhance solubility poorly soluble lipid-lowering agent ezetimibe (EZ), a member class II as per Biopharmaceutics Classification System (BCS). The drug was formulated nanostructured lipid carrier (NLC) employing ultrasonication technique. A response surface D-optimal design employed...

10.1021/acsomega.3c08428 article EN cc-by-nc-nd ACS Omega 2024-02-11

The use of doxorubicin (DOX) to treat various tumors is limited by its cardiotoxicity. This study aimed investigate and compare the cardioprotective effects nicotinamide (NAM) alfacalcidol (1α(OH)D3), against DOX-induced Sprague Dawley male rats received DOX (5 mg/kg, i.p.) once/week for four consecutive weeks. Treated groups either NAM (600 p.o.) 28 days or 1α(OH)D3 (0.5 ug/kg, elicited marked cardiac tissue injury manifested elevated serum cardiotoxicity indices, conduction...

10.1016/j.biopha.2021.111679 article EN Biomedicine & Pharmacotherapy 2021-05-21

Abstract Purpose Up-to-date literature offers limited data about utilizing atorvastatin calcium (ATV) as a promising chondroprotective agent in osteoarthritis (OA). So, this study aims to develop depot intra-articular (IA) delivery system for ATV enhance its deposition the articular joint. Methods A 3 D-optimal design was implemented prepare ATV-loaded lecithin-coated zein nanoparticles. The optimized formulation (Opt-LCZN) selected and imaged using transmission electron microscope according...

10.1007/s40005-024-00666-x article EN cc-by Journal of Pharmaceutical Investigation 2024-02-20

Chronic kidney disease (CKD), a global health concern, is highly prevalent among adults. Presently, there are limited therapeutic options to restore function. This study aimed investigate the potential of breast milk mesenchymal stem cells (Br-MSCs) and their derived exosomes in CKD. Eighty adult male Sprague Dawley rats were randomly assigned one six groups, including control, nephropathy, nephropathy + conditioned media (CM), Br-MSCs, Br-MSCs (Br-MSCs-EXOs), Br-MSCs-EXOs. Before...

10.3390/pharmaceutics15082149 article EN cc-by Pharmaceutics 2023-08-16

High dose methotrexate (HDMTX) is an important chemotherapy agent in the treatment of cancers children.Treatment with HDMTX can cause unwanted side effects and induces many types toxicity (e.g.renal toxicity, liver neurotoxicity, hematologic pulmonary gastrointestinal cutaneomucous toxicity).Adding leucovorin rescue provides advantage safe administration.However, therapy should be initiated only when plasma monitoring available to determine adequacy drug removal risk serious...

10.21608/jabps.2020.44872.1106 article EN Journal of advanced Biomedical and Pharmaceutical Sciences 2020-12-25
Coming Soon ...